← Open Payments lookup

SEAMUS CONNOLLY: Open Payments

NPI 1932648599 · INDIO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,308 in 124 payments from 15 companies in 2025. Trend: 2023 $1,848 · 2024 $4,216 · 2025 $3,308

Food & beverage: $3,204Education: $104
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.31$755
Janssen Pharmaceuticals, Inc13$415
Teva Pharmaceuticals USA, Inc.10$376
Neurocrine BioSciences, Inc.8$373
Alkermes, Inc.12$356
Vanda Pharmaceuticals Inc.8$296
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$228
Takeda Pharmaceuticals U.S.A., Inc.11$141
Lundbeck LLC10$136
ABBVIE INC.4$100

Products named: REXULTI, INGREZZA, FANAPT, AUSTEDO XR, INVEGA SUSTENNA, ARISTADA, CAPLYTA, TRINTELLIX.

Industry payments across CA — which companies pay providers there.